ArticleJAMA oncology2018

Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy.

Roberto Ferrara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.